Matches in Nanopublications for { ?s ?p "[CXCR4 inhibition to decrease cell proliferation and to control the leukemic burden may provide a novel therapeutic strategy in patients with advanced FLT3-ITD-positive AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion description "[CXCR4 inhibition to decrease cell proliferation and to control the leukemic burden may provide a novel therapeutic strategy in patients with advanced FLT3-ITD-positive AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.
- NP783760.RASn-YebFZvjzwpVL6T7DZIfLmrMaOjN9ZsGF7cYLONJE130_assertion description "[CXCR4 inhibition to decrease cell proliferation and to control the leukemic burden may provide a novel therapeutic strategy in patients with advanced FLT3-ITD-positive AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783760.RASn-YebFZvjzwpVL6T7DZIfLmrMaOjN9ZsGF7cYLONJE130_provenance.
- NP784650.RAOIkRwynxlGEqvULHnBpZM9qtBpCs_vylrS-hR9FWmPE130_assertion description "[CXCR4 inhibition to decrease cell proliferation and to control the leukemic burden may provide a novel therapeutic strategy in patients with advanced FLT3-ITD-positive AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784650.RAOIkRwynxlGEqvULHnBpZM9qtBpCs_vylrS-hR9FWmPE130_provenance.